ITIF

Assessing the Clout of US National Power Industries vs. China
A select group of advanced, globally traded industries serves as the bedrock of U.S. technological leadership, economic power, and national security. Policymakers need to closely monitor the relative strength and vulnerability of its production capabilities.

The Alarming Performance of US Advanced Technology Product Trade
Over the last decade, U.S. trade performance has deteriorated significantly in advanced industries. That is a major problem because these industries have high fixed costs and require substantial investments in R&D, so they depend on large customer bases to achieve scale economies and remain globally competitive.

Internal Value Chains Remain Dependent on China Even as Multinationals Shift Production to America
Advanced manufacturers based in East Asia are expanding investment into the U.S. economy. Yet, many of their internal value chains remain anchored in China, giving the PRC significant leverage over U.S. interests. U.S. policymakers should respond both defensively and offensively.
Public Sector AI Adoption Index

Governments are entering a critical phase in the adoption of AI. It is already contributing to everyday public sector work, and the question is no longer whether to adopt AI, but how to do so both effectively and responsibly. The Public Sector AI Adoption Index 2026 focuses on the human side of AI adoption, examining how it is experienced by public servants every day.
Policy Reforms to Launch US Space Innovation

Competitiveness in the global space economy should be a priority for the United States, but ineffective regulations weigh down the American commercial space industry. While last year’s executive order was a good start, additional regulatory reforms are necessary to address key roadblocks to U.S. space capabilities.
How NIH-Funded Science Supports US Biopharmaceutical Innovation

NIH-funded research supports the foundation for industry to develop vaccines and therapies, exemplifying deep public-private R&D complementarity. As global competition intensifies, expanding NIH funding will be key to protecting American health, supporting U.S. biopharmaceutical competitiveness, and ensuring national power and security.
Lessons From France’s Nuclear Program

France has embarked on an ambitious program to build at least six new large nuclear reactors, applying lessons from recent overruns and delays. While success is far from guaranteed, there are important lessons for the United States as it seeks to jump-start its own nuclear sector through recent ambitious executive orders.
A Shot at a Healthier Future: The Transformative Potential of GLP-1s

Obesity affects over 42 percent of U.S. adults, costing the nation more than $400 billion annually. Traditional weight-loss methods alone have proved to be insufficient in addressing this growing public health burden. But GLP-1 receptor agonists now offer the potential to profoundly transform obesity care. Public policies should support their wider adoption.























